Biotech | December 09, 2025
Agilent and Monash Malaysia launch cutting-edge BioDiscovery hub to boost regional biotech
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Growing patent filings and tier-2 innovators reflect expanding national research base
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Subscribe To Our Newsletter & Stay Updated
